An Electronic Brief Alcohol Intervention for Women Attending a Breast Screening Service (Health4Her)
An Electronic Brief Intervention to Reduce Alcohol Consumption Intentions, Improve Alcohol Literacy, and Reduce Harmful Use Among Women Attending a Breast Screening Service: a Randomised Controlled Trial
1 other identifier
interventional
143
1 country
1
Brief Summary
Alcohol is a major modifiable risk factor for female breast cancer; yet, awareness of this risk remains surprisingly low and is not systematically addressed in healthcare settings. This study aim to test the effectiveness of a co-designed, automated brief alcohol intervention (Health4Her-Automated) in reducing women's drinking intentions, improving alcohol literacy, and reducing consumption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 13, 2023
CompletedFirst Posted
Study publicly available on registry
August 31, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 6, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedFebruary 9, 2024
December 1, 2023
1 month
August 13, 2023
February 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Drinking intentions
Change in next-month drinking intentions (5-point scale: 1, not at all; 5, to a very large extent)
immediately post-randomisation
Secondary Outcomes (8)
Drinking intentions
4-weeks post-randomisation
Drinking intentions - standard drinks
4-weeks post-randomisation
Proportion of participants intending to reduce alcohol consumption
immediately post-randomisation
Proportion of participants intending to reduce alcohol consumption
4-weeks post-randomisation
Knowledge of alcohol as a breast cancer risk factor
4-weeks post-randomisation
- +3 more secondary outcomes
Study Arms (2)
Brief alcohol intervention (Health4Her-Automated) + lifestyle health promotion
EXPERIMENTALThe intervention arm will receive: * brief alcohol intervention * lifestyle health promotion focused on physical activity and maintaining a healthy weight for reducing breast cancer risk. Participants will receive an iPad and earphones to self-complete the intervention. Alcohol and lifestyle information will be delivered by way of an animation on an iPad, and self-completed activities to reinforce intervention content.
Lifestyle health promotion
OTHERThe control arm will receive: * lifestyle health promotion focused on physical activity and maintaining a healthy weight for reducing breast cancer risk. Participants will receive an iPad and earphones to self-complete the control intervention. Lifestyle information will be delivered by way of an animation on an iPad, and a self-completed activity to reinforce intervention content.
Interventions
Embedded within the lifestyle health promotion provided in both conditions, participants randomised to the experimental condition will receive a brief alcohol intervention. The brief alcohol intervention will comprise information and behaviour-change content regarding alcohol consumption, including: messaging around alcohol risks/harms (with a focus on alcohol use and breast cancer risk), positive-framed messaging on the health benefits of reducing alcohol intake, and alcohol harm-reduction / behaviour change strategies (e.g. drink counting, goal setting, behaviour substitution, problem solving). Post-session information will be provided via email (i.e. electronic brochure summarising brief alcohol intervention content).
Lifestyle health promotion, focused on physical activity and maintaining a healthy weight for reducing breast cancer risk, will be provided. Post-session information will be provided via email (i.e. electronic brochure summarising nutrition for maintaining a healthy weight).
Eligibility Criteria
You may qualify if:
- Female
- + years of age
- Attending routine breast screening
- With or without a breast cancer history
- Reporting any level of alcohol consumption
You may not qualify if:
- Not able to read or comprehend English to enable participation
- No access to a computer, tablet or smartphone to complete follow-up assessment
- Participation in the pilot Health4Her trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Turning Pointlead
- Monash Universitycollaborator
- Eastern Healthcollaborator
- BreastScreen Victoriacollaborator
- Lifepoolcollaborator
- Shades of Pinkcollaborator
Study Sites (1)
Maroondah BreastScreen
Ringwood East, Victoria, 3135, Australia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jasmin Grigg, PhD
Turning Point, Eastern Health; Monash University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- The on-site researcher responsible for recruitment will not be blind to treatment assignment; the participating women self-completing baseline assessment, intervention, immediate post-intervention and 4-week follow-up assessments will be blinded to treatment assignment. The researcher who oversees follow-up assessment data collection will be blinded to treatment assignment.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 13, 2023
First Posted
August 31, 2023
Study Start
September 1, 2023
Primary Completion
October 6, 2023
Study Completion
December 1, 2023
Last Updated
February 9, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share
There is not Ethics approval to seek patient permission to share data outside this study.